Detection of endogenous iron deposits in the injured mouse spinal cord through high-resolution ex vivo and in vivo MRI

NMR in Biomedicine

Volumn 26, Issue 2, 2013, Pages 141-150

  Blomster, Linda V ^a,b   Cowin, Gary J ^a   Kurniawan, Nyoman D ^a   Ruitenberg, Marc J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Astrogliosis; Haemorrhage; Neural scar; Neurodegeneration; Neurotrauma; Oxidative stress; Secondary injury

Indexed keywords

ASTROGLIOSIS; HAEMORRHAGE; NEURAL SCAR; NEURODEGENERATION; NEUROTRAUMA; SECONDARY INJURY;

DEPOSITS; ENZYME INHIBITION; MAGNETIC RESONANCE IMAGING; MAMMALS; OXIDATIVE STRESS;

IRON DEPOSITS;

GLIAL FIBRILLARY ACIDIC PROTEIN; IRON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOPSY; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CONTUSION; EX VIVO STUDY; FEMALE; HISTOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MACROPHAGE; MICROGLIA; MOUSE; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGODENDROGLIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPATIOTEMPORAL ANALYSIS; SPINAL CORD INJURY;

ANIMALS; BIOLOGICAL MARKERS; FEMALE; IMAGE ENHANCEMENT; IRON; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED C57BL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPINAL CORD INJURIES; TISSUE DISTRIBUTION;

ANIMALIA; MUS; WALLERIA;

EID: 84872605108     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2829     Document Type: Article

References (47)

1. Bunge RP, Puckett WR, Becerra JL, Marcillo A, Quencer RM. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv. Neurol. 1993; 59: 75-89.
2. Norenberg MD, Smith J, Marcillo A. The pathology of human spinal cord injury: defining the problems. J. Neurotrauma, 2004; 21(4): 429-440.
3. McDonald JW, Sadowsky C. Spinal-cord injury. Lancet, 2002; 359(9304): 417-425.
4. Ghasemlou N, Kerr BJ, David S. Tissue displacement and impact force are important contributors to outcome after spinal cord contusion injury. Exp. Neurol. 2005; 196(1): 9-17.
5. Lucin KM, Sanders VM, Jones TB, Malarkey WB, Popovich PG. Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp. Neurol. 2007; 207(1): 75-84.
6. David BT, Steward O. Deficits in bladder function following spinal cord injury vary depending on the level of the injury. Exp. Neurol. 2010; 226(1): 128-135.
7. Schwab ME, Bartholdi D. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. 1996; 76(2): 319-370.
8. Juurlink BH, Paterson PG. Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J. Spinal Cord Med. 1998; 21(4): 309-334.
9. Mackay-Sim A, Feron F, Cochrane J, Bassingthwaighte L, Bayliss C, Davies W, Fronek P, Gray C, Kerr G, Licina P, Nowitzke A, Perry C, Silburn PA, Urquhart S, Geraghty T. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 2008; 131(Pt 9): 2376-2386.
10. Do-Dai DD, Brooks MK, Goldkamp A, Erbay S, Bhadelia RA. Magnetic resonance imaging of intramedullary spinal cord lesions: a pictorial review. Curr. Probl. Diagn. Radiol. 2010; 39(4): 160-185.
11. Cohen-Adad J, El Mendili MM, Lehericy S, Pradat PF, Blancho S, Rossignol S, Benali H. Demyelination and degeneration in the injured human spinal cord detected with diffusion and magnetization transfer MRI. Neuroimage 2011; 55(3): 1024-1033.
12. Gensel JC, Donnelly DJ, Popovich PG. Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages. Expert Opin. Ther. Targets 2011; 15(4): 505-518.
13. Scheff SW, Dhillon HS. Creatine-enhanced diet alters levels of lactate and free fatty acids after experimental brain injury. Neurochem. Res. 2004; 29(2): 469-479.
14. Nishi RA, Liu H, Chu Y, Hamamura M, Su MY, Nalcioglu O, Anderson AJ. Behavioral, histological, and ex vivo magnetic resonance imaging assessment of graded contusion spinal cord injury in mice. J. Neurotrauma 2007; 24(4): 674-689.
15. Gonzalez-Lara LE, Xu X, Hofstetrova K, Pniak A, Brown A, Foster PJ. In vivo magnetic resonance imaging of spinal cord injury in the mouse. J. Neurotrauma 2009; 26(5): 753-762.
16. Gonzalez-Lara LE, Xu X, Hofstetrova K, Pniak A, Chen Y, McFadden CD, Martinez-Santiesteban FM, Rutt BK, Brown A, Foster PJ. The use of cellular magnetic resonance imaging to track the fate of iron-labeled multipotent stromal cells after direct transplantation in a mouse model of spinal cord injury. Mol. Imaging Biol. 2011; 13(4): 702-711.
17. Herrera JJ, Sundberg LM, Zentilin L, Giacca M, Narayana PA. Sustained expression of vascular endothelial growth factor and angiopoietin-1 improves blood-spinal cord barrier integrity and functional recovery after spinal cord injury. J. Neurotrauma 2010; 27(11): 2067-2076.
18. Byrnes KR, Fricke ST, Faden AI. Neuropathological differences between rats and mice after spinal cord injury. J. Magn. Reson. Imaging 2010; 32(4): 836-846.
19. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 2000; 20(11): 4106-4114.
20. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 2006; 23(5): 635-659.
21. Johnson GA, Cofer GP, Gewalt SL, Hedlund LW. Morphologic phenotyping with MR microscopy: the visible mouse. Radiology 2002; 222(3): 789-793.
22. Blackwell ML, Farrar CT, Fischl B, Rosen BR. Target-specific contrast agents for magnetic resonance microscopy. Neuroimage 2009; 46(2): 382-393.
23. Ullmann JF, Cowin G, Kurniawan ND, Collin SP. Magnetic resonance histology of the adult zebrafish brain: optimization of fixation and gadolinium contrast enhancement. NMR Biomed. 2010; 23(4): 341-346.
24. Haase A, Frahm J, Matthaei D, Hanicke W, Merboldt KD. Flash imaging - rapid NMR imaging using low flip-angle pulses. J. Magn. Reson. 1986; 67(2): 258-266.
25. Rosset A, Spadola L, Ratib O. OsiriX: an open-source software for navigating in multidimensional DICOM images. J. Digit. Imaging 2004; 17(3): 205-216.
26. Cowin GJ, Butler TJ, Kurniawan ND, Watson C, Wallace RH. Magnetic resonance microimaging of the spinal cord in the SOD1 mouse model of amyotrophic lateral sclerosis detects motor nerve root degeneration. Neuroimage 2011; 58(1): 69-74.
27. Schonberg DL, McTigue DM. Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation. Exp. Neurol. 2009; 218(1): 64-74.
28. Gaviria M, Bonny JM, Haton H, Jean B, Teigell M, Renou JP, Privat A. Time course of acute phase in mouse spinal cord injury monitored by ex vivo quantitative MRI. Neurobiol. Dis. 2006; 22(3): 694-701.
29. Kozlowski P, Raj D, Liu J, Lam C, Yung AC, Tetzlaff W. Characterizing white matter damage in rat spinal cord with quantitative MRI and histology. J. Neurotrauma, 2008; 25(6): 653-676.
30. Ellingson BM, Ulmer JL, Kurpad SN, Schmit BD. Diffusion tensor MR imaging in chronic spinal cord injury. Am. J. Neuroradiol. 2008; 29(10): 1976-1982.
31. Ellingson BM, Schmit BD, Kurpad SN. Lesion growth and degeneration patterns measured using diffusion tensor 9.4-T magnetic resonance imaging in rat spinal cord injury. J. Neurosurg. Spine 2010; 13(2): 181-192.
32. Ahrens ET, Young WB, Xu H, Pusateri LK. Rapid quantification of inflammation in tissue samples using perfluorocarbon emulsion and fluorine-19 nuclear magnetic resonance. Biotechniques 2011; 50(4): 229-234.
33. Qian J, Herrera JJ, Narayana PA. Neuronal and axonal degeneration in experimental spinal cord injury: in vivo proton magnetic resonance spectroscopy and histology. J. Neurotrauma 2010; 27(3): 599-610.
34. Wang M, Dai Y, Han Y, Haacke EM, Dai J, Shi D. Susceptibility weighted imaging in detecting hemorrhage in acute cervical spinal cord injury. Magn. Reson. Imaging, 2011; 29(3): 365-373.
35. Bilgen M, Rumboldt Z. Neuronal and vascular biomarkers in syringomyelia: investigations using longitudinal MRI. Biomark. Med. 2008; 2(2): 113-124.
36. Liu JB, Tang TS, Xiao DS. Changes of free iron content and its correlation with lipid peroxidation after experimental spinal cord injury. Chin. J. Traumatol. 2004; 7(4): 229-232.
37. Rathore KI, Kerr BJ, Redensek A, Lopez-Vales R, Jeong SY, Ponka P, David S. Ceruloplasmin protects injured spinal cord from iron-mediated oxidative damage. J. Neurosci. 2008; 28(48): 12 736-12 747.
38. Koszyca B, Manavis J, Cornish RJ, Blumbergs PC. Patterns of immunocytochemical staining for ferritin and transferrin in the human spinal cord following traumatic injury. J. Clin. Neurosci. 2002; 9(3): 298-301.
39. Heye N, Kastrup O, Terstegge K, Faiss JH, Iglesias JR. Superficial siderosis of the central nervous system. Arch. Gerontol. Geriatr. 1994; 18(3): 181-190.
40. Rathnasamy G, Ling EA, Kaur C. Iron and iron regulatory proteins in amoeboid microglial cells are linked to oligodendrocyte death in hypoxic neonatal rat periventricular white matter through production of proinflammatory cytokines and reactive oxygen/nitrogen species. J. Neurosci. 2011; 31(49): 17 982-17 995.
41. Paterniti I, Mazzon E, Emanuela E, Paola RD, Galuppo M, Bramanti P, Cuzzocrea S. Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator. Free Radic. Res., 2010; 44(6): 694-709.
42. Brazda N, Muller HW. Pharmacological modification of the extracellular matrix to promote regeneration of the injured brain and spinal cord. Prog. Brain Res. 2009; 175: 269-281.
43. Izawa T, Yamate J, Franklin RJ, Kuwamura M. Abnormal iron accumulation is involved in the pathogenesis of the demyelinating dmy rat but not in the hypomyelinating mv rat. Brain Res. 2010; 1349: 105-114.
44. Dunning MD, Lakatos A, Loizou L, Kettunen M, Ffrench-Constant C, Brindle KM, Franklin RJ. Superparamagnetic iron oxide-labeled Schwann cells and olfactory ensheathing cells can be traced in vivo by magnetic resonance imaging and retain functional properties after transplantation into the CNS. J. Neurosci. 2004; 24(44): 9799-9810.
45. Dunning MD, Kettunen MI, Ffrench Constant C, Franklin RJ, Brindle KM. Magnetic resonance imaging of functional Schwann cell transplants labelled with magnetic microspheres. Neuroimage 2006; 31(1): 172-180.
46. Geffner LF, Santacruz P, Izurieta M, Flor L, Maldonado B, Auad AH, Montenegro X, Gonzalez R, Silva F. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant. 2008; 17(12): 1277-1293.
47. Hu SL, Zhang JQ, Hu X, Hu R, Luo HS, Li F, Xia YZ, Li JT, Lin JK, Zhu G, Feng H. In vitro labeling of human umbilical cord mesenchymal stem cells with superparamagnetic iron oxide nanoparticles. J. Cell. Biochem. 2009; 108(2): 529-535.